TimesSquare Capital Management LLC lessened its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 345,840 shares of the company's stock after selling 9,910 shares during the period. TimesSquare Capital Management LLC owned approximately 1.90% of Addus HomeCare worth $34,200,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in ADUS. Natixis grew its position in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the period. Meeder Asset Management Inc. bought a new stake in shares of Addus HomeCare during the 4th quarter valued at $77,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Addus HomeCare during the 4th quarter valued at $86,000. Cibc World Markets Corp bought a new stake in shares of Addus HomeCare during the 4th quarter valued at $204,000. Finally, Atria Investments Inc bought a new stake in shares of Addus HomeCare during the 4th quarter valued at $209,000. Institutional investors own 95.35% of the company's stock.
Addus HomeCare Price Performance
Addus HomeCare stock traded down $2.32 during mid-day trading on Tuesday, hitting $109.43. The stock had a trading volume of 141,518 shares, compared to its average volume of 165,886. The firm has a market capitalization of $2.01 billion, a P/E ratio of 24.70, a P/E/G ratio of 1.58 and a beta of 0.81. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20. The firm's 50 day moving average is $112.61 and its 200 day moving average is $110.27. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. The business had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business's quarterly revenue was up 20.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.21 EPS. On average, sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on ADUS shares. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. Macquarie reissued an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday, June 10th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a report on Friday, June 20th. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $142.57.
Get Our Latest Stock Analysis on Addus HomeCare
Insider Buying and Selling
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the sale, the executive vice president owned 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 4.60% of the stock is currently owned by insiders.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.